Toronto-Dominion Bank »

Karyopharm Therapeutics shares owned by Toronto-Dominion Bank

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Toronto-Dominion Bank from 13F filings

Historical chart of Toronto-Dominion Bank investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Toronto-Dominion Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Toronto-Dominion Bank

Quarter filed Position value Share count Share price at filing
2026-06-30 $302k 31k 9.77

More positions owned by Toronto-Dominion Bank

NVIDIA Corporation (NVDA)
eBay (EBAY)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Rbc Cad (RY)
Intel Corporation (INTC)
Micron Technology (MU)
Cibc Cad (CM)
Alphabet Cap Stk Cl A (GOOGL)
Sandisk Corp (SNDK)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)

View all positions for Toronto-Dominion Bank

Top funds holding Karyopharm Therapeutics

RA Capital Management
Adage Capital Partners GP
Acorn Capital Advisors
Goldman Sachs Group
BlackRock
Vanguard Capital Management
Catalio Capital Management
Avidity Partners Management
Two Sigma Investments
Kalehua Capital Management
NEA Management Company
Susquehanna International
Geode Capital Management
Ghisallo Capital Management
Soleus Capital Management

View all funds holding Karyopharm Therapeutics